Clinical Trial Update: A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the safety and effectiveness of NOA VOLUME Injectable Gel versus JUVÉDERM VOLUMA XC for improving mid-face volume in adul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mid-face Volume Deficit

Drugs mentioned

• JUVÉDERM VOLUMA XC (hyaluronic acid dermal filler)
• NOA VOLUME Injectable Gel

Snippet

Sponsor: AbbVie | Conditions: Mid Face Volume Deficit | Phase 3 | Status: RECRUITING